Latest Institutional Transactions on Ab Cellera Biologics Inc. (ABCL)
This table provides information on the latest institutional transactions involving Ab Cellera Biologics Inc. (ABCL) stock. The table includes the name of the institution, the type of operation (buy or sell), whether options were involved, the number of shares exchanged, the range of values for the transaction, and the number of shares held by the institution after the transaction has occurred.
Report Date | Institution (Fund) | Operation | Option | Shares change | Value Range | Shares Held | Trade History |
---|---|---|---|---|---|---|---|
May 14, 2021
Q1 2021
|
Eventide Asset Management, LLC
Boston, MA |
SELL
|
- |
-300KClosed |
$6.99M - $16M
|
0
$0
|
|
May 13, 2021
Q1 2021
|
Capital Asset Advisory Services LLC
Haslett, MI |
SELL
|
- |
-93Closed |
$2.17K - $4.95K
|
0
$0
|
|
May 11, 2021
Q1 2021
|
Jennison Associates LLC
|
SELL
|
- |
-17.5KClosed |
$409K - $933K
|
0
$0
|
|
May 06, 2021
Q1 2021
|
Quantitative Systematic Strategies LLC
|
SELL
|
- |
-5.27KClosed |
$123K - $281K
|
0
$0
|
|
Apr 12, 2021
Q1 2021
|
Valeo Financial Advisors, LLC
|
SELL
|
- |
-39Closed |
$908 - $2.07K
|
0
$0
|
|
Q4 2020 | |||||||
Feb 16, 2021
Q4 2020
|
Founders Fund Vii Management, LLC
San Francisco, CA |
BUY
|
- |
3.77MNew |
$147M - $222M
|
3.77M
$15.9M
|
|
Feb 16, 2021
Q4 2020
|
Stanley Druckenmiller
Duquesne Family Office LLC | New York, Ny
|
BUY
|
- |
660KNew |
$25.7M - $38.9M
|
660K
$2.78M
|
|
Feb 12, 2021
Q4 2020
|
Harvard Management CO Inc
Boston, MA |
BUY
|
- |
4.11MNew |
$160M - $242M
|
4.11M
$17.3M
|